With its stock down 17% over the past three months, it is easy to disregard Optimax Holdings Berhad (KLSE:OPTIMAX). But if you pay close attention, you might gather that its strong financials ...

In this article, we are going to take a look at where Vistra Corp. (NYSE:VST) stands against Richard Chilton's other stock picks. Richard Chilton is a veteran investor and the founder of Chilton ...

In this article, we are going to take a look at where Vistra Corp. (NYSE:VST) stands against the other stocks. As per BlackRock, 2025 started with a bumpy ride for the US stocks. That being said ...

In this article, we are going to take a look at where Vistra Corp. (NYSE:VST) stands against other AI stocks to watch amid market volatility. The uncertain macroeconomic environment is diminishing ...

His Optimax Eye Specialist Center, which opened in Kuala Lumpur in 1995, got listed as Optimax Holdings in 2020. His daughter Sandy is CEO while Tan is executive deputy chairman. Even before ...

Below is Validea's guru fundamental report for VISTRA CORP (VST). Of the 22 guru strategies we follow, VST rates highest using our P/E/Growth Investor model based on the published strategy of ...

In trading on Wednesday, shares of Vistra Corp (Symbol: VST) crossed above their 200 day moving average of $123.47, changing hands as high as $125.58 per share. Vistra Corp shares are currently ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

PETALING JAYA: Optimax Holdings Bhd will seek growth through the expansion of its eye centres in strategic locations in the country as well as to Cambodia. Chief executive officer Sandy Tan said ...

PETALING JAYA: Optimax Holdings Bhd ’s earnings are expected to recover this year, on the back of continued growth in total surgery numbers, normalisation of pre-operation costs, as well as the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...